Substance P: The Pain Peptide That Can Also Stop Pain — How Ion Channels Decide Which

This is a narrative review of published studies examining substance P's role in pain signaling. The authors analyzed evidence on SP-modulated ion channels (calcium, potassium, and others), NK1 receptor signaling in different cell types, and the differential downstream effector systems that determine whether SP produces pain or pain relief.

Pain management remains one of the biggest challenges in medicine, with opioid alternatives urgently needed. If substance P — one of the most studied neuropeptides — can actually suppress pain under certain conditions, understanding exactly how could open an entirely new approach to analgesic drug design based on channeling SP's anti-pain pathway rather than blocking it entirely.

The opioid crisis has made finding non-opioid painkillers one of medicine's top priorities. NK1 receptor antagonists (which block substance P) were developed as painkillers but largely failed in clinical trials — perhaps because they blocked both the pain-causing AND pain-relieving actions of SP. This review suggests a more nuanced approach: instead of blocking SP entirely, selectively activate its anti-nociceptive pathway. This represents a paradigm shift in how we think about neuropeptide-based pain therapy.

As a narrative review, this paper synthesizes existing literature without new experimental data. Much of the anti-nociceptive evidence comes from animal models, and the conditions under which SP suppresses vs. promotes pain in humans are not yet fully defined. The clinical translatability of the anti-nociceptive pathway remains theoretical.